In the BioHarmony Drug Report Database

"Preview" Icon

Sincalide

Kinevac (sincalide) is a protein pharmaceutical. Sincalide was first approved as Kinevac on 1982-01-01. It is known to target gastrin/cholecystokinin type B receptor and cholecystokinin receptor type A. Kinevac’s patent is valid until 2022-08-16 (FDA).

 

Trade Name

 

Kinevac
 

Common Name

 

sincalide
 

ChEMBL ID

 

CHEMBL1121
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Sincalide structure rendering